Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway

References

• International Diabetes Federation. IDF Diabetes . Brussels, Belgium: International Diabetes Federation; 2017.
   Google Scholar
• Dounousi E , Duni A , Leivaditis K , Vaios V , Eleftheriadis T , Liakopoulos V . Improvements in the management of diabetic nephropathy. Rev Diabet Stud . 2015;12(1–2):119–133. doi:10.1900/RDS.2015.12.119 26676665
   PubMedGoogle Scholar
• Colafella KM , Hilliard LM , Denton KM . Epochs in the depressor/pressor balance of the renin-angiotensin system. Clin Sci . 2016;130(10):761–771. doi:10.1042/CS20150939 27128801
   PubMed Web of Science ®Google Scholar
• Fukuda A , Wickman LT , Venkatareddy MP , et al. Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int . 2012;81(1):40–55. doi:10.1038/ki.2011.306 21937979
   PubMed Web of Science ®Google Scholar
• Guo DF , Chenier I , Tardif V , Orlov SN , Inagami T . Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane. Biochem Biophys Res Commun . 2003;310(4):1254–1265. doi:10.1016/j.bbrc.2003.09.154 14559250
   PubMed Web of Science ®Google Scholar
• Lee CH , Wu SL , Chen JC , et al. Eriobotrya japonica leaf and its triterpenes inhibited lipopolysaccharide-induced cytokines and inducible enzyme production via the nuclear factor-kappaB signaling pathway in lung epithelial cells. Am J Chin Med . 2008;36(6):1185–1198. doi:10.1142/S0192415X0800651X 19051345
   PubMed Web of Science ®Google Scholar
• Liu J . Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol . 1995;49(2):57–68. doi:10.1016/0378-8741(95)90032-2 8847885
   PubMed Web of Science ®Google Scholar
• Lu X , Fan Q , Xu L , et al. Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression. PLoS One . 2015;10(2):e0117400. doi:10.1371/journal.pone.0117400 25689721
   PubMed Web of Science ®Google Scholar
• Wang EM , Fan QL , Yue Y , Xu L . Ursolic acid attenuates high glucose-mediated mesangial cell injury by inhibiting the phosphatidylinositol 3-kinase/akt/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway. Med Sci Monit . 2018;24846–24854.
   Web of Science ®Google Scholar
• Ninichuk V , Clauss S , Kulkarni O , et al. Late onset of Ccl2 blockade with the spiegelmer mNOX-E36-3ʹPEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice. Am J Pathol . 2008;172(3):628–637. doi:10.2353/ajpath.2008.070601 18258851
   PubMed Web of Science ®Google Scholar
• Xu HL , Wang XT , Cheng Y , et al. Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats. Biomed Pharmacother . 2018;105:915–921. doi:10.1016/j.biopha.2018.06.055 30021385
   PubMed Web of Science ®Google Scholar
• Wang XT , Gong Y , Zhou B , et al. Ursolic acid ameliorates oxidative stress, inflammation and fibrosis in diabetic cardiomyopathy rats. Biomed Pharmacother . 2018;97:1461–1467. doi:10.1016/j.biopha.2017.11.032 29156537
   PubMed Web of Science ®Google Scholar
• Rahimi Z . The role of renin angiotensin aldosterone system genes in diabetic nephropathy. Can J Diabetes . 2016;40(2):178–183. doi:10.1016/j.jcjd.2015.08.016 26619914
   PubMed Web of Science ®Google Scholar
• Bakris GL , Williams M , Dworkin L , et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National kidney foundation hypertension and diabetes executive committees working group. Am J Kidney Dis . 2000;36(3):646–661. doi:10.1053/ajkd.2000.16225 10977801
   PubMed Web of Science ®Google Scholar
• Brenner BM , Cooper ME , de Zeeuw D , et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med . 2001;345(12):861–869. doi:10.1056/NEJMoa011161 11565518
   PubMed Web of Science ®Google Scholar
• Lewis EJ , Hunsicker LG , Clarke WR , et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med . 2001;345(12):851–860. doi:10.1056/NEJMoa011303 11565517
   PubMed Web of Science ®Google Scholar
• Savoia C , Burger D , Nishigaki N , Montezano A , Touyz RM . Angiotensin II and the vascular phenotype in hypertension. Expert Rev Mol Med . 2011;13:e11. doi:10.1017/S1462399411001815 21450123
   PubMed Web of Science ®Google Scholar
• Guo DF , Chenier I , Lavoie JL , et al. Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney. Hypertension . 2006;48(3):453–459. doi:10.1161/01.HYP.0000230664.32874.52 16801480
   PubMed Web of Science ®Google Scholar
• Mederle K , Schweda F , Kattler V , et al. The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension. Crit Care . 2013;17(4):R130. doi:10.1186/cc12809 23844607
   PubMed Web of Science ®Google Scholar
• Castrop H , Hocherl K , Kurtz A , Schweda F , Todorov V , Wagner C . Physiology of kidney renin. Physiol Rev . 2010;90(2):607–673.20393195
   PubMed Web of Science ®Google Scholar
• Kanauchi M , Nishioka H , Hashimoto T . Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron . 2002;91(2):327–329. doi:10.1159/000058412 12053073
   PubMed Web of Science ®Google Scholar
• Kim N , Jung Y , Nam M , et al. Angiotensin II affects inflammation mechanisms via AMPK-related signalling pathways in HL-1 atrial myocytes. Sci Rep . 2017;7(1):10328. doi:10.1038/s41598-017-09675-3 28871102
   PubMed Web of Science ®Google Scholar
• Sonta T , Inoguchi T , Matsumoto S , et al. In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker. Biochem Biophys Res Commun . 2005;330(2):415–422. doi:10.1016/j.bbrc.2005.02.174 15796899
   PubMed Web of Science ®Google Scholar
• Hecker L , Vittal R , Jones T , et al. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med . 2009;15(9):1077–1081. doi:10.1038/nm.2005 19701206
   PubMed Web of Science ®Google Scholar
• Gorin Y . Nox4 as a potential therapeutic target for treatment of uremic toxicity associated to chronic kidney disease. Kidney Int . 2013;83(4):541–543. doi:10.1038/ki.2012.434 23538692
   PubMed Web of Science ®Google Scholar
• Gorin Y , Wauquier F . Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease. Mol Cells . 2015;38(4):285–296. doi:10.14348/molcells.2015.0010 25824546
   PubMed Web of Science ®Google Scholar
• Jha JC , Gray SP , Barit D , et al. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. J Am Soc Nephrol . 2014;25(6):1237–1254. doi:10.1681/ASN.2013070810 24511132
   PubMed Web of Science ®Google Scholar
• Yin B , Whyatt RM , Perera FP , Randall MC , Cooper TB , Santella RM . Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Radic Biol Med . 1995;18(6):1023–1032. doi:10.1016/0891-5849(95)00003-G 7628728
   PubMed Web of Science ®Google Scholar
• Loft S , Poulsen HE . Cancer risk and oxidative DNA damage in man. J Mol Med (Berl) . 1996;74(6):297–312. doi:10.1007/BF00207507 8862511
   PubMed Web of Science ®Google Scholar
• Hussain H , Green IR , Ali I , et al. Ursolic acid derivatives for pharmaceutical use: a patent review (2012–2016). Expert Opin Ther Pat . 2017;27(9):1061–1072. doi:10.1080/13543776.2017.1344219 28637397
   PubMed Web of Science ®Google Scholar
• Zhou Y , Li JS , Zhang X , Wu YJ , Huang K , Zheng L . Ursolic acid inhibits early lesions of diabetic nephropathy. Int J Mol Med . 2010;26(4):565–570. doi:10.3892/ijmm_00000500 20818497
   PubMed Web of Science ®Google Scholar
• Qi MY , Yang JJ , Zhou B , Pan DY , Sun X . Study on the protective effect of ursolic acid on alloxan-induced diabetic renal injury and its underlying mechanisms. Zhongguo Ying Yong Sheng Li Xue Za Zhi . 2014;30(5):445–448.25571638
   PubMedGoogle Scholar
• Jayaprakasam B , Olson LK , Schutzki RE , Tai MH , Nair MG . Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). J Agric Food Chem . 2006;54(1):243–248. doi:10.1021/jf0520342 16390206
   PubMed Web of Science ®Google Scholar
• Li D , Ren D , Luo Y , et al. Protective effects of ursolic acid against hepatotoxicity and endothelial dysfunction in mice with chronic high choline diet consumption. Chem Biol Interact . 2016;258:102–107. doi:10.1016/j.cbi.2016.08.019 27567547
   PubMed Web of Science ®Google Scholar
• Chu X , He X , Shi Z , et al. Ursolic acid increases energy expenditure through enhancing free fatty acid uptake and β-oxidation via an UCP3/AMPK-dependent pathway in skeletal muscle. Mol Nutr Food Res . 2015;59(8):1491–1503. doi:10.1002/mnfr.v59.8 25944715
   PubMed Web of Science ®Google Scholar
• Ullevig SL , Zhao Q , Zamora D , et al. Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis. Atherosclerosis . 2011;219(2):409–416. doi:10.1016/j.atherosclerosis.2011.06.013 21752377
   PubMed Web of Science ®Google Scholar
• Jia Y , Kim S , Kim J , et al. Ursolic acid improves lipid and glucose metabolism in high-fat-fed C57BL/6J mice by activating peroxisome proliferator-activated receptor alpha and hepatic autophagy. Mol Nutr Food Res . 2015;59(2):344–354. doi:10.1002/mnfr.201400399 25418615
   PubMed Web of Science ®Google Scholar
• Xu L , Fan Q , Wang X , et al. Ursolic acid improves podocyte injury caused by high glucose. Nephrol Dialysis Transplant . 2015;32:8.
   Web of Science ®Google Scholar